Kummeth Charles R. 4

Accession 0001062993-23-016040

CIK 0000842023other

Filed

Aug 7, 8:00 PM ET

Accepted

Aug 8, 5:31 PM ET

Size

26.5 KB

Accession

0001062993-23-016040

Form 4

Period: 2023-08-05

DirectorChief Executive Officer

Transactions

Exercise/Conversion
Common Stock
2023-08-05+51,516→ 1,310,282 total
Tax Payment
Common Stock
2023-08-05$82.17/sh−31,962$2,626,318→ 1,278,320 total
Exercise/Conversion
Restricted Stock Units
2023-08-05−51,516→ 0 total
→ Common Stock (51,516 underlying)

Holdings

Common Stock
(indirect: By Step-Son)
400
Stock Options (Right to Buy)
Exercise: $31.26Exp: 2024-08-09→ Common Stock (779,084 underlying)
779,084
Stock Options (Right to Buy)
Exercise: $47.60Exp: 2026-08-07→ Common Stock (342,900 underlying)
342,900
Stock Options (Right to Buy)
Exercise: $47.60Exp: 2026-08-07→ Common Stock (228,600 underlying)
228,600
Restricted Stock Units
→ Common Stock (32,064 underlying)
32,064
Stock Options (Right to Buy)
Exercise: $120.45Exp: 2028-08-06→ Common Stock (125,260 underlying)
125,260
Stock Options (Right to Buy)
Exercise: $44.33Exp: 2025-08-08→ Common Stock (361,336 underlying)
361,336
Stock Options (Right to Buy)
Exercise: $44.33Exp: 2025-08-08→ Common Stock (240,888 underlying)
240,888
Stock Options (Right to Buy)
Exercise: $66.97Exp: 2027-08-05→ Common Stock (299,768 underlying)
299,768
Stock Options (Right to Buy)
Exercise: $66.97Exp: 2027-08-05→ Common Stock (66,600 underlying)
66,600
Stock Options (Right to Buy)
Exercise: $66.97Exp: 2027-08-05→ Common Stock (153,180 underlying)
153,180
Stock Options (Right to Buy)
Exercise: $120.45Exp: 2028-08-06→ Common Stock (83,504 underlying)
83,504
Common Stock
(indirect: By Step-Daughter)
400
Stock Options (Right to Buy)
Exercise: $94.52Exp: 2029-08-15→ Common Stock (600,000 underlying)
600,000
Restricted Stock Units
→ Common Stock (52,900 underlying)
52,900

Footnotes (9)

[F1]Includes 7,128 shares of restricted stock for which the risk of forfeiture will lapse on August 6, 2024.
[F2]Fully exercisable.
[F3]Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
[F4]On 8/5/2023, the Board of Directors certified vesting of 51,516 performance RSUs.
[F5]17,632 shares vest on each of 8/15/2023 and 8/15/2025, and 17,636 shares vest on 8/15/2024.
[F6]Options to purchase 38,292 shares vest on 8/5/21 and options to purchase 38,296 shares vest on each of 8/5/22, 8/5/23 and 8/5/24.
[F7]Vests in full or in part on 8/6/2024 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
[F8]Options to purchase 20,876 shares vest on each of 8/6/2022, 8/6/2023, 8/6/2024 and 8/6/2025.
[F9]600,000 options vest in full or in part on 7/1/2024 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).

Documents

1 file

BIO-TECHNE Corp

CIK 0000842023

Entity typeother